A citation-based method for searching scientific literature


List of co-cited articles
22 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Non-invasive prediction of recurrence in bladder cancer by detecting somatic TERT promoter mutations in urine.
Françoise Descotes, Norelyakin Kara, Myriam Decaussin-Petrucci, Eric Piaton, Florence Geiguer, Claire Rodriguez-Lafrasse, Jean E Terrier, Jonathan Lopez, Alain Ruffion. Br J Cancer 2017
44
42

Telomerase reverse transcriptase promoter mutations in bladder cancer: high frequency across stages, detection in urine, and lack of association with outcome.
Yves Allory, Willemien Beukers, Ana Sagrera, Marta Flández, Miriam Marqués, Mirari Márquez, Kirstin A van der Keur, Lars Dyrskjot, Irene Lurkin, Marcel Vermeij,[...]. Eur Urol 2014
159
42

Telomerase reverse transcriptase mediates EMT through NF-κB signaling in tongue squamous cell carcinoma.
Yan Wu, Chunxiang Bian, Chunlin Zhen, Liu Liu, Zhenghong Lin, Muhammad Farrukh Nisar, Mei Wang, Jörg W Bartsch, Enyi Huang, Ping Ji,[...]. Oncotarget 2017
15
42

Transcription Regulation of the Human Telomerase Reverse Transcriptase (hTERT) Gene.
Muhammad Khairul Ramlee, Jing Wang, Wei Xun Toh, Shang Li. Genes (Basel) 2016
85
28

Novel anticancer therapeutics targeting telomerase.
Maria Ruden, Neelu Puri. Cancer Treat Rev 2013
198
28

TERT promoter mutations in telomere biology.
Barbara Heidenreich, Rajiv Kumar. Mutat Res Rev Mutat Res 2017
90
28

Telomerase regulates MYC-driven oncogenesis independent of its reverse transcriptase activity.
Cheryl M Koh, Ekta Khattar, Shi Chi Leow, Chia Yi Liu, Julius Muller, Wei Xia Ang, Yinghui Li, Guido Franzoso, Shang Li, Ernesto Guccione,[...]. J Clin Invest 2015
96
28

Roles of telomeres and telomerase in cancer, and advances in telomerase-targeted therapies.
Mohammad A Jafri, Shakeel A Ansari, Mohammed H Alqahtani, Jerry W Shay. Genome Med 2016
262
28

Telomerase reverse transcriptase (TERT) promoter mutation analysis of benign, malignant and reactive urothelial lesions reveals a subpopulation of inverted papilloma with immortalizing genetic change.
Liang Cheng, Darrell D Davidson, Mingsheng Wang, Antonio Lopez-Beltran, Rodolfo Montironi, Lisha Wang, Puay-Hoon Tan, Gregory T MacLennan, Sean R Williamson, Shaobo Zhang. Histopathology 2016
28
28

TERT promoter mutations in bladder cancer affect patient survival and disease recurrence through modification by a common polymorphism.
P Sivaramakrishna Rachakonda, Ismail Hosen, Petra J de Verdier, Mahdi Fallah, Barbara Heidenreich, Charlotta Ryk, N Peter Wiklund, Gunnar Steineck, Dirk Schadendorf, Kari Hemminki,[...]. Proc Natl Acad Sci U S A 2013
221
28

Toward Personalised Liquid Biopsies for Urothelial Carcinoma: Characterisation of ddPCR and Urinary cfDNA for the Detection of the TERT 228 G>A/T Mutation.
Ilaria J Russo, Yongwon Ju, Naheema S Gordon, Maurice P Zeegers, K K Cheng, Nicholas D James, Richard T Bryan, Douglas G Ward. Bladder Cancer 2018
28
28

Recurrent TERT promoter mutations in urothelial carcinoma and potential clinical applications.
Boaz Kurtis, Jian Zhuge, Caroline Ojaimi, Fei Ye, Dongming Cai, David Zhang, John T Fallon, Minghao Zhong. Ann Diagn Pathol 2016
25
28

Frequency of TERT promoter mutations in human cancers.
João Vinagre, Ana Almeida, Helena Pópulo, Rui Batista, Joana Lyra, Vasco Pinto, Ricardo Coelho, Ricardo Celestino, Hugo Prazeres, Luis Lima,[...]. Nat Commun 2013
545
28

TERT promoter mutations occur early in urothelial neoplasia and are biomarkers of early disease and disease recurrence in urine.
Isaac Kinde, Enrico Munari, Sheila F Faraj, Ralph H Hruban, Mark Schoenberg, Trinity Bivalacqua, Mohamad Allaf, Simeon Springer, Yuxuan Wang, Luis A Diaz,[...]. Cancer Res 2013
170
28

TERT promoter mutations and TERT mRNA but not FGFR3 mutations are urinary biomarkers in Han Chinese patients with urothelial bladder cancer.
Kun Wang, Tiantian Liu, Cheng Liu, Yan Meng, Xiaotian Yuan, Li Liu, Nan Ge, Jikai Liu, Chang Wang, Hongbo Ren,[...]. Oncologist 2015
23
28

Combined genetic and epigenetic alterations of the TERT promoter affect clinical and biological behavior of bladder cancer.
Ricardo Leão, Donghyun Lee, Arnaldo Figueiredo, Thomas Hermanns, Peter Wild, Martin Komosa, Irene Lau, Mathew Mistry, Nuno Miguel Nunes, Aryeh J Price,[...]. Int J Cancer 2019
28
28

Detection of multiple mutations in urinary exfoliated cells from male bladder cancer patients at diagnosis and during follow-up.
Rossana Critelli, Francesca Fasanelli, Marco Oderda, Silvia Polidoro, Manuela Bianca Assumma, Clara Viberti, Mirko Preto, Paolo Gontero, Giuseppina Cucchiarale, Irene Lurkin,[...]. Oncotarget 2016
31
28

Mutations in TERT promoter and FGFR3 and telomere length in bladder cancer.
Ismail Hosen, P Sivaramakrishna Rachakonda, Barbara Heidenreich, Petra J de Verdier, Charlotta Ryk, Gunnar Steineck, Kari Hemminki, Rajiv Kumar. Int J Cancer 2015
61
28

NF-kappaB p65 modulates the telomerase reverse transcriptase in the HepG₂ hepatoma cell line.
Qing-Ping Zuo, Shi-Kun Liu, Zuo-Jun Li, Bing Li, Yu-Lu Zhou, Ren Guo, Li-Hua Huang. Eur J Pharmacol 2011
25
28

Telomerase reverse transcriptase expression elevated by avian leukosis virus integration in B cell lymphomas.
Feng Yang, Rena R Xian, Yingying Li, Tatjana S Polony, Karen L Beemon. Proc Natl Acad Sci U S A 2007
32
28

Immortalization of chicken preadipocytes by retroviral transduction of chicken TERT and TR.
Wei Wang, Tianmu Zhang, Chunyan Wu, Shanshan Wang, Yuxiang Wang, Hui Li, Ning Wang. PLoS One 2017
31
28

TERT biology and function in cancer: beyond immortalisation.
Ana Pestana, João Vinagre, Manuel Sobrinho-Simões, Paula Soares. J Mol Endocrinol 2017
42
28


Genes involved in senescence and immortalization.
A S Lundberg, W C Hahn, P Gupta, R A Weinberg. Curr Opin Cell Biol 2000
227
14

G-quadruplex formation at the 3' end of telomere DNA inhibits its extension by telomerase, polymerase and unwinding by helicase.
Quan Wang, Jia-quan Liu, Zhao Chen, Ke-wei Zheng, Chang-yue Chen, Yu-Hua Hao, Zheng Tan. Nucleic Acids Res 2011
91
14

Antagonistic effects of telomerase on cancer and aging in K5-mTert transgenic mice.
Eva González-Suárez, Christoph Geserick, Juana M Flores, María A Blasco. Oncogene 2005
63
14






Conditional telomerase induction causes proliferation of hair follicle stem cells.
Kavita Y Sarin, Peggie Cheung, Daniel Gilison, Eunice Lee, Ruth I Tennen, Estee Wang, Maja K Artandi, Anthony E Oro, Steven E Artandi. Nature 2005
311
14

Feedback regulation of telomerase reverse transcriptase: new insight into the evolving field of telomerase in cancer.
Xiao-Qin Wu, Cheng Huang, Xu He, Yuan-Yao Tian, De-Xi Zhou, Yong He, Xin-Hua Liu, Jun Li. Cell Signal 2013
37
14


Targeting critical steps of cancer metastasis and recurrence using telomerase template antagonists.
Z Gunnur Dikmen, Taner Ozgurtas, Sergei M Gryaznov, Brittney-Shea Herbert. Biochim Biophys Acta 2009
15
14

Telomere biology: Rationale for diagnostics and therapeutics in cancer.
Philippe Rousseau, Chantal Autexier. RNA Biol 2015
16
14

The telomerase activator TA-65 elongates short telomeres and increases health span of adult/old mice without increasing cancer incidence.
Bruno Bernardes de Jesus, Kerstin Schneeberger, Elsa Vera, Agueda Tejera, Calvin B Harley, Maria A Blasco. Aging Cell 2011
157
14

Expanding the clinical phenotype of autosomal dominant dyskeratosis congenita caused by TERT mutations.
Lina Basel-Vanagaite, Inderjeet Dokal, Hannah Tamary, Abraham Avigdor, Ben Zion Garty, Alexander Volkov, Tom Vulliamy. Haematologica 2008
33
14


Green tea catechin, epigallocatechin-3-gallate (EGCG): mechanisms, perspectives and clinical applications.
Brahma N Singh, Sharmila Shankar, Rakesh K Srivastava. Biochem Pharmacol 2011
745
14


Involvement of 14-3-3 proteins in nuclear localization of telomerase.
H Seimiya, H Sawada, Y Muramatsu, M Shimizu, K Ohko, K Yamane, T Tsuruo. EMBO J 2000
238
14

Massively parallel sequencing of phyllodes tumours of the breast reveals actionable mutations, and TERT promoter hotspot mutations and TERT gene amplification as likely drivers of progression.
Salvatore Piscuoglio, Charlotte Ky Ng, Melissa Murray, Kathleen A Burke, Marcia Edelweiss, Felipe C Geyer, Gabriel S Macedo, Akiko Inagaki, Anastasios D Papanastasiou, Luciano G Martelotto,[...]. J Pathol 2016
68
14


Telomere dynamics in arteries and mononuclear cells of diabetic patients: effect of diabetes and of glycemic control.
Orit Uziel, Joelle Attal Singer, Vladimir Danicek, Gideon Sahar, Evgeny Berkov, Michael Luchansky, Abigail Fraser, Ron Ram, Meir Lahav. Exp Gerontol 2007
91
14

The Telomeric Complex and Metabolic Disease.
Henriette Kirchner, Fozia Shaheen, Hannes Kalscheuer, Sebastian M Schmid, Henrik Oster, Hendrik Lehnert. Genes (Basel) 2017
31
14


The cationic porphyrin TMPyP4 down-regulates c-MYC and human telomerase reverse transcriptase expression and inhibits tumor growth in vivo.
Cory L Grand, Haiyong Han, Rubén M Muñoz, Steve Weitman, Daniel D Von Hoff, Laurence H Hurley, David J Bearss. Mol Cancer Ther 2002
269
14


Telomerase inhibition with a novel G-quadruplex-interactive agent, telomestatin: in vitro and in vivo studies in acute leukemia.
T Tauchi, K Shin-ya, G Sashida, M Sumi, S Okabe, J H Ohyashiki, K Ohyashiki. Oncogene 2006
157
14


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.